NM_000767.5:c.1459C>A
Variant summary
The NM_000767.5(CYP2B6):c.1459C>A (p.Arg487Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0000713 (AC=115) in the gnomAD database across 1,613,602 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0013. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_000767.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_benign. The variant received -1 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| B3Computational evidence does not support deleterious effect | Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3 |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000767.5. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CYP2B6 | TSL:1MANE Select | c.1459C>A p.Arg487Ser | missense | Exon 9 of 9 | Prot: ENSP00000324648.2 UniProt: | |
CYP2B6 | TSL:1 | n.812C>A | non_coding_transcript_exon | Exon 3 of 3 | Prot: | |
CYP2B6 | c.1114C>A p.Arg372Ser | missense | Exon 7 of 7 | Prot: ENSP00000533417.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.000329 | AC:50 | Hom:0 | AN:152096 | Cov:31 |
GnomAD2 exomes | AF: 0.000120 | AC:30 | AN:250440 | ||
GnomAD4 exome | AF: 0.0000438 | AC:64 | Hom:0 | AN:1461388 | Cov:32 |
GnomAD4 genome | AF: 0.000335 | AC:51 | Hom:0 | AN:152214 | Cov:31 |
TOPMed (Bravo) | AF: 0.000416 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000356 | AC:2 | Hom:285 | AN:56180 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
Epi25 | 0.000143 | 6 | 41956 | 0.000135 | 9 | 66882 |
SCHEMA | 0.000246 | 29 | 117668 | 0.000303 | 61 | 201322 |
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Uncertain | 12 | |
AlphaMissense | Benign | 0.24 | |
BayesDel_addAF | Benign | -0.55 | T |
BayesDel_noAF | Benign | -0.58 | |
CADD | Benign | 0.93 | |
DANN | Benign | 0.61 | |
DEOGEN2 | Benign | 0.0045 | T |
Eigen | Benign | -1.6 | |
Eigen_PC | Benign | -1.6 | |
FATHMM_MKL | Benign | 0.018 | N |
FuncVEP CTI | Benign | 0.033 | |
GPN-Star LLR | N/A | -4.3 | |
GPN-Star score | N/A | 4.3 | |
LIST_S2 | Benign | 0.34 | T |
M_CAP | Benign | 0.0073 | T |
MetaRNN | Benign | 0.018 | T |
MetaSVM | Benign | -1.0 | T |
Mutation Taster | N/A | 82/18 | polymorphism |
MutationAssessor | Benign | 0.39 | N |
PhyloP100 | Benign | -0.85 | |
popEVE | Benign | -2.4 | |
PrimateAI | Benign | 0.20 | T |
PROVEAN | Benign | 0.83 | N |
REVEL | Benign | 0.027 | |
Sift | Benign | 0.48 | T |
Sift4G | Benign | 0.57 | T |
Varity_R | N/A | 0.46 | |
VESM-3B | Benign | -5.7 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.